tirzepatide to semaglutide switch Switching from Tirzepatide: What to Expect — Affinity Whole Health Switching Tirzepatide to Semaglutide: Clinical

In the burgeoning field of weight management, the new class of medications called GLP-1 receptor agonists has made a remarkable entrance

Some options have stronger evidence for weight loss

The muscle loss problem explained GLP-1 agonist weight loss typically includes significant lean mass reduction

As a peptide that declines with age and intersects with many well-established longevity pathways, it stands to have significant effects on age-related decline - Cardiometabolic health: Research suggests improvements in several markers associated with metabolic syndrome, but more studies are required regarding cardiovascular outcomes in humans